Key result
18FDG PET/CT detects distant metastasis with ~86% accuracy in pediatric sarcoma, outperforming PET and conventional imaging.
Why the study?
The diagnostic accuracy of 18FDG PET/CT in staging pediatric sarcomas, particularly for nodal and distant metastases, required clarification.
Does 18FDG PET/CT improve diagnostic accuracy for staging nodal and distant metastases in pediatric patients with sarcomas compared to PET alone or conventional imaging?
Observational (n=50)
Does 18FDG PET/CT improve diagnostic accuracy for staging nodal and distant metastases in pediatric patients with sarcomas compared to PET alone or conventional imaging?
18FDG PET/CT provides significantly higher diagnostic accuracy for detecting distant metastases in pediatric sarcomas compared to PET alone or conventional imaging.
Answers are grounded in this paper and cite their sources.
May support 18FDG PET/CT staging in pediatric sarcomas; leaves open prospective validation against conventional imaging.
The present study was conducted to clarify the diagnostic accuracy of 18F-fluoro-2-deoxy-D-glucose (18FDG) positron emission tomography (PET)/computed tomography (CT) in the staging in pediatric sarcomas. Fifty pediatric patients with histologically proven sarcomas who underwent 18FDG PET/CT before treatment were evaluated retrospectively for the detection of nodal and distant metastases. Diagnostic accuracy of 18FDG PET/CT in detecting nodal and distant metastases was compared with that of 18FDG PET and conventional imaging (CI). The images were reviewed and a diagnostic consensus was reached by 3 observers. REFERENCE standard was histologic examination in 15 patients and confirmation of an obvious progression in size of the lesions on follow-up examinations. Nodal metastasis was correctly assessed in 48 patients (96%) with PET/CT, in contrast to 43 patients (86%) with PET, and 46 patients (92%) with CI. Diagnostic accuracies of nodal metastasis in 3 modalities were similar. Using PET/CT, distant metastasis was correctly assigned in 43 patients (86%), whereas interpretation based on PET alone or CI revealed distant metastasis in 33 patients (66%) and 35 patients (70%), respectively. Diagnostic accuracy of distant metastasis with PET/CT was significantly higher than that of PET (P=0.002) or CI (P=0.008). False negative results regarding distant metastasis by PET/CT in 7 patients (14%) were caused by subcentimetric lesions (n=4), bone marrow lesion (n=2), and soft tissue lesions (n=1). PET/CT is more accurate and probably more cost-effective than PET alone or CI regarding distant metastasis in pediatric sarcomas.
No takes yet. Share an insight, caveat, or question.
Tateishi et al. (2007) conducted an observational in Pediatric sarcomas (n=50). 18FDG PET/CT vs. 18FDG PET alone and conventional imaging was evaluated on Diagnostic accuracy of distant metastasis (p=0.002 vs PET, 0.008 vs CI). 18FDG PET/CT correctly detected distant metastasis in 86% of pediatric sarcoma patients, demonstrating higher diagnostic accuracy than PET alone or conventional imaging.
Synapse has enriched 10 related papers. Consider them for comparative context: